Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

Our industry-leading litigation practice regularly represents the world’s largest branded pharmaceutical companies in high-stakes, high-risk litigation. Drug makers trust our litigators to handle their blockbuster Hatch-Waxman, BPCIA, and competitor litigation matters because they possess the unique combination of technical, legal, and industry expertise necessary for success.

Examples of our biotechnology and pharmaceutical work include:

  • Patenting groundbreaking life sciences innovations, including tissue engineering, therapeutic agents and methods, antibodies, and genetically engineered animals
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting IP due diligence on billions of dollars in deal value for pharmaceutical investments, mergers, and acquisitions
  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Litigating ANDA cases on behalf of branded pharmaceuticals
  • Representing biotechnology and pharmaceutical companies in post-grant proceedings at the PTAB, as well as coordinating post-grant and district court litigation strategies

Notable Wins

Fish Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead

Fish won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of litigation and business misconduct constituting “unclean hands.”

Read more about this precedential opinion here and here.

Fish Wipes Out $2.5B Patent Verdict Against Gilead Sciences

Fish & Richardson won a motion for Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict against its client Gilead Sciences Inc. in federal court in Delaware.

Read about this historic win here and here.

Recent Webinars

2022

2021

2020

2019

2018

Mayo/Myriad Tracker

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
Event
July 13th, 2022 | 1:30 pm EDT
Webinar | Patent Portfolio Management: Strategies for Navigating Due Diligence for Startups
Webinar
Event
June 21st, 2022 | 4:05 pm EDT
LSX USA World Congress 2022 | Biotech Startup/Early-Stage CEO Forum
Speaking Engagement
Sponsorship
Event
June 14th, 2022 | 10:00 am CEST
Kisaco Research: Biologics, Cell & Gene Legal Summit
Speaking Engagement
Sponsorship
Event
May 10th, 2022 | 2:30 pm BST
LSX World Congress
Speaking Engagement
Sponsorship
Event
June 8th, 2022 | 1:30 pm EDT
Webinar | Patent Prosecution: Best Practices for Startups
Webinar
Event
May 21st, 2022 | 8:00 pm EDT
Chinese Antibody Society 2022 mAbTalk Symposium: Emerging Targets for Immuno-oncology
Sponsorship
News
March 31, 2022
Fish Attorneys Author IP Litigator Article, "Regenxbio v. Sarepta: Make Sure You’re Safely Within the Safe Harbor Before Using a 'Research Tool'"
Articles
Event
May 24th, 2022 | 12:30 pm EDT
Momentum's 2nd Due Diligence for Life Sciences Conference
Speaking Engagement
Conference/Convention
Sponsorship
Event
May 18th, 2022 | 5:30 pm EDT
Delaware Bio Annual Gala
Sponsorship
Event
May 4th, 2022 | 9:20 am EDT
Longwood Healthcare Leaders Spring Meeting | How M&A Spurs Innovation
Speaking Engagement
Sponsorship
Event
April 14th, 2022 | 1:30 pm EDT
Webinar | Viewing the Orange Book Under a Microscope: The Regulatory Framework & its Implications for Branded Drug Makers
Webinar
Blog
March 8, 2022
Orange Book 101
Author: Kelly Allenspach Del Dotto
load more topics